Literatur

Autor(en) Titel Quelle Links
Faber J, Wingerter A, Neu MA, Henninger N, Eckerle S, Münzel T, Lackner KJ, Beutel ME, Blettner M, Rathmann W, Peters A, Meisinger C, Linkohr B, Neuhauser H, Kaatsch P, Spix C, Schneider A, Merzenich H, Panova-Noeva M, Prochaska JH, Wild PS Burden of cardiovascular risk factors and cardiovascular disease in childhood cancer survivors: data from the German CVSS-study. European heart journal 2018 May 1; 39: 1555    
Faivre L, Meerpohl J, Da Costa L, Marie I, Nouvel C, Gnekow A, Bender-Götze C, Bauters F, Coiffier B, Peaud PY, Rispal P, Berrebi A, Berger C, Flesch M, Sagot P, Varet B, Niemeyer C, Tchernia G, Leblanc T High-risk pregnancies in Diamond-Blackfan anemia: a survey of 64 pregnancies from the French and German registries. Haematologica 2006, 91: 530    
Falkenstein F, Gessi M, Kandels D, Ng HK, Schmidt R, Warmuth-Metz M, Bison B, Krauss J, Kortmann RD, Timmermann B, Thomale UW, Albert MH, Pekrun A, Maaß E, Gnekow AK, Pietsch T Prognostic impact of distinct genetic entities in pediatric diffuse glioma WHO-grade II-Report from the German/Swiss SIOP-LGG 2004 cohort. International journal of cancer 2020, Epup ahead of print    
Fanconi G Familiäre infantile perniziosaartige Anämie (perniziöses Blutbild und Konstitution). Jahrb Kinderheilk 1927,: 257    
Fanconi G Familial constitutional panmyelocytopathy, Fanconi's anemia (F. A.). I. Clinical aspects. Semin Hematol 1967, 4: 233    
Farahati J, Bucsky P, Parlowsky T, Mader U, Reiners C Characteristics of differentiated thyroid carcinoma in children and adolescents with respect to age, gender, and histology. Cancer 1997, 80: 2156    
Farahati J, Parlowsky T, Mader U, Reiners C, Bucsky P Differentiated thyroid cancer in children and adolescents. Langenbecks Arch Surg 1998, 383: 235    
Farrar JE, Vlachos A, Atsidaftos E, Carlson-Donohoe H, Markello TC, Arceci RJ, Ellis SR, Lipton JM, Bodine DM Ribosomal protein gene deletions in Diamond-Blackfan anemia. Blood 2011, 118: 6943    
Farashi S, Harteveld CL Molecular basis of α-thalassemia. Blood cells, molecules & diseases 2017    
Fasano RM, Meier ER, Hulbert ML Cerebral vasculopathy in children with sickle cell anemia. Blood cells, molecules & diseases 2015, 54: 17    
Favrot M, Ambros P, Schilling F, Frappaz D, Combaret V, Berthold F, Dominici C, Erttmann R, Esteve J, Jenkner A, Kerbl R, Mann J, Mathieu P, Parker L, Powell J, Philip T Comparison of the diagnostic and prognostic value of biological markers in neuroblastoma. Proposal for a common methodology of analysis. SENSE group. Ann Oncol 1996, 7: 607    
Favara B, Feller A, Pauli M, Jaffe E, Weiss L, Arico M, Bucsky P, Egeler R, Elinder G, Gadner H, Gresik M, Henter J, Imashuku S, Janka-Schaub G, Jaffe R, Ladisch S, Nezelof C, Pritchard J Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol 1997, 29: 157    
Favaloro EJ Clinical utility of closure times using the platelet function analyzer-100/200. American journal of hematology 2017, 92: 398    
Fazekas T, Eickhoff P, Lawitschka A, Knotek B, Pötschger U, Peters C Exhaled nitric oxide and pulmonary complications after paediatric stem cell transplantation. European journal of pediatrics 2012 Feb 16;    
Fazekas T, Attarbaschi A, Lawitschka A, Seidel M, Pötschger U, Peters C, Mann G, Gadner H, Matthes-Martin S Lethal pulmonary complications after pediatric allogeneic hematopoietic stem cell transplantation. The Pediatric infectious disease journal 2012, 31: 115    
Fengler R, Baumgarten E, Buchmann S, Creutzig U, Harbott J, Ludwig R, Henze G Biklonale Leukämie (O-ALL/AMoL) mit 11;19 Translokation und Trisomie X bei einem 8 Monate alten Mädchen. Klinische Pädiatrie 1986, 198: 178    
Fenaux P, Chastang C, Chevret S, Sanz M, Dombret H, Archimbaud E, Fey M, Rayon C, Huguet F, Sotto JJ, Gardin C, Makhoul PC, Travade P, Solary E, Fegueux N, Bordessoule D, Miguel JS, Link H, Desablens B, Stamatoullas A, Deconinck E, Maloisel F, Castaigne S, Preudhomme C, Degos L A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood 1999 Aug 15; 94: 1192    
Ferrari A, Casanova M, Bisogno G, Mattke A, Meazza C, Gronchi A, Cecchetto G, Fidani P, Kunz D, Treuner J, Carli M Hemangiopericytoma in pediatric ages. Cancer 2001, 92: 2692    
Ferris Tortajada J, Garcia Castell J, Berbel Tornero O, Clar Gimeno S Risk factors for non-Hodgkin’s lymphomas. An Esp Pediatr 2001, 55: 230    
Ferris Tortajada J, Garcia Castell J, Lopez Andreu JA, Clar Gimeno S, Berbel Tornero O Risk factors for Hodgkin's lymphomas. An Esp Pediatr 2001, 55: 239    
Ferrari A, Bisogno G, Casanova M, Meazza C, Piva L, Cecchetto G, Zanetti I, Pilz T, Mattke A, Treuner J, Carli M Paratesticular rhabdomyosarcoma. J Clin Oncol 2002, 20: 449    
Ferrari A, Casanova M, Bisogno G, Cecchetto G, Meazza C, Gandola L, Garaventa A, Mattke A, Treuner J, Carli M Malignant vascular tumors in children and adolescents. Med Pediatr Oncol 2002, 39: 109    
Ferrari A, Casanova M, Bisogno G, Mattke A, Meazza C, Gandola L, Sotti G, Cecchetto G, Harms D, Koscielniak E, Treuner J, Carli M Clear cell sarcoma of tendons and aponeuroses in pediatric patients. Cancer 2002, 94: 3269    
Ferrari A, Bisogno G, Casanova M, Brecht I, Alaggio R, Cecchetto G, Provenzi M, Koscielniak E, Treuner J, Carli M Is alveolar histotype a prognostic factor in paratesticular rhabdomyosarcoma? Pediatr Blood Cancer 2004, 42: 134    
Ferrari A, Casanova M, Bisogno G, Carli M, Treuner J What chemotherapy should alveolar paratesticular rhabdomyosarcoma receive? Pediatr Blood Cancer 2004, 43: 295    
Ferrari A, Brecht IB, Koscielniak E, Casanova M, Scagnellato A, Bisogno G, Alaggio R, Cecchetto G, Catania S, Meazza C, Int-Veen C, Kirsch S, Dantonello T, Carli M, Treuner J The role of adjuvant chemotherapy in children and adolescents with surgically resected, high-risk adult-type soft tissue sarcomas. Pediatric blood & cancer 2005, 45: 128    
Ferrari A, Bisogno G, De Salvo GL, Indolfi P, Perilongo G, Cecchetto G, Italian Study on Rare Tumours in Paediatric Age (TREP),Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) The challenge of very rare tumours in childhood: the Italian TREP project. European journal of cancer 2007, 43: 654    
Ferrari A, Schneider DT, Bisogno G, EXPeRT Board The founding of the European Cooperative Study Group on Pediatric Rare Tumors--EXPeRT. Expert review of anticancer therapy 2013, 13: 1    
Lê PQ, Gulbis B, Dedeken L, Dupont S, Vanderfaeillie A, Heijmans C, Huybrechts S, Devalck C, Efira A, Dresse MF, Rozen L, Benghiat FS, Ferster A Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment. Pediatric blood & cancer 2015, 62: 1956    
Feuchtinger T Susceptibility to childhood leukemia. Blood 2011 118: 1189    
Fichtner I, Lemm M, Becker M, Berthold F Effects of amifostine (WR-2721, ethyol) on tumor growth and pharmacology of cytotoxic drugs in human xenotransplanted neuroblastomas. Anticancer Drugs 1997, 8: 174    
Fichtner I, Paal K, Borgmann A, Badiali L, Wurm R, Henze G Chemo- and radiation sensitivity of xenografted acute lymphoblastic leukemias--correlation to the expression of multidrug resistance proteins. Anticancer Res 2003, 23: 2657    
Filipovich AH, Mathur A, Kamat D, Shapiro RS Primary inmunodeficiencies: genetic risk factors for lymphoma. Cancer Res 1992, 52: 5465    
Filipovich AH Life-threatening hemophagocytic syndromes: current outcomes with hematopoietic stem cell transplantation. Pediatric transplantation 2005, 9 Suppl 7: 87    
Finger PT, Czechonska G, Demirci H, Rausen A Chemotherapy for retinoblastoma: a current topic. Drugs 1999, 58: 983    
Fine B, Stanulla M, Schrappe M, Ho M, Viehmann S, Harbott J, Boxer L Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia. Blood 2004, 103: 1043    
Fischer M, Berthold F Characterization of the gene expression profile of neuroblastoma cell line IMR-5 using serial analysis of gene expression. Cancer Lett 2003, 190: 79    
Fischer M, Skowron M, Berthold F Reliable transcript quantification by real-time reverse transcriptase-polymerase chain reaction in primary neuroblastoma using normalization to averaged expression levels of the control genes HPRT1 and SDHA. The Journal of molecular diagnostics 2005, 7: 89    
Fischer M, Oberthuer A, Brors B, Kahlert Y, Skowron M, Voth H, Warnat P, Ernestus K, Hero B, Berthold F Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome. Clinical cancer research : an official journal of the American Association for Cancer Research 2006, 12: 5118    
Fischer M, Spitz R, Oberthür A, Westermann F, Berthold F Risk estimation of neuroblastoma patients using molecular markers. Klinische Padiatrie 2008, 220: 137    
Fischer M, Bauer T, Oberthür A, Hero B, Theissen J, Ehrich M, Spitz R, Eils R, Westermann F, Brors B, König R, Berthold F Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11q. Oncogene 2010, 29: 865    
Fischer M, Berthold F The role of complex genomic alterations in neuroblastoma risk estimation. Genome medicine 2010 May 19; 2: 31    
Fischer J, Pohl A, Volland R, Hero B, Dübbers M, Cernaianu G, Berthold F, von Schweinitz D, Simon T Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months. BMC cancer 2017 Aug 4; 17: 520    
Flentje M, Weirich A, Potter R, Ludwig R Hepatotoxicity in irradiated nephroblastoma patients during postoperative treatment according to SIOP9/GPOH. Radiother Oncol 1994, 31: 222    
Flentje M, Weirich A, Graf N, Potter R, Zimmerman H, Ludwig R Abdominal irradiation in unilateral nephroblastoma and its impact on local control and survival. Int J Radiat Oncol Biol Phys 1998, 40: 163    
Fletcher O, Easton D, Anderson K, Gilham C, Jay M, Peto J Lifetime risks of common cancers among retinoblastoma survivors. Journal of the National Cancer Institute 2004, 96: 357    
Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F WHO Classification of Tumours of Soft Tissue and Bone. WHO Classification of Tumours 4th edn. International Agency for Research on Cancer , Lyon, 2013    
Fleischhack G, Rutkowski S, Pfister SM, Pietsch T, Tippelt S, Warmuth-Metz M, Bison B, van Velthoven-Wurster V, Messing-Jünger M, Kortmann RD, Timmermann B, Slavc I, Witt O, Gnekow A, Hernáiz Driever P, Kramm C, Benesch M, Frühwald MC, Hasselblatt M, Müller HL, Sörensen N, Kordes U, Calaminus G ZNS-Tumoren. in: Niemeyer C, Eggert A (Hrsg.): Pädiatrische Hämatologie und Onkologie. Springer-Verlag GmbH Deutschland, 2. vollständig überarbeitete Auflage 2018, 359    
Fleischhack G, Massimino M, Warmuth-Metz M, Khuhlaeva E, Janssen G, Graf N, Rutkowski S, Beilken A, Schmid I, Biassoni V, Gorelishev SK, Kramm C, Reinhard H, Schlegel PG, Kortmann RD, Reuter D, Bach F, Iznaga-Escobar NE, Bode U Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study. Journal of neuro-oncology 2019, 143: 107    
Flotho C, Valcamonica S, Mach-Pascual S, Schmahl G, Corral L, Ritterbach J, Hasle H, Arico M, Biondi A, Niemeyer C RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML). Leukemia 1999, 13: 32    
Flower KB, Hoppin JA, Lynch CF, Blair A, Knott C, Shore DL, Sandler DP Cancer risk and parental pesticide application in children of Agricultural Health Study participants. Environ Health Perspect 2004, 112: 631    
Flohr T, Schrauder A, Cazzaniga G, Panzer-Grümayer R, van der Velden V, Fischer S, Stanulla M, Basso G, Niggli FK, Schäfer BW, Sutton R, Koehler R, Zimmermann M, Valsecchi MG, Gadner H, Masera G, Schrappe M, van Dongen JJ, Biondi A, Bartram CR, International BFM Study Group (I-BFM-SG) Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008, 22: 771    
Flotho C, Vraetz T, Lang P, Niemeyer CM, Strahm B Successful double umbilical cord blood transplantation for relapsed juvenile myelomonocytic leukemia. Leukemia 2013, 27: 988    
Fluss J, Dinomais M, Kossorotoff M, Vuillerot C, Darteyre S, Chabrier S Perspectives in neonatal and childhood arterial ischemic stroke. Expert review of neurotherapeutics 2017, 17: 135    
Foell JL, Max D, Giersberg C, Körholz D, Staege MS Sensitivity of Hodgkin's lymphoma cell lines to the cell cycle inhibitor roscovitine. Anticancer research 2008, 28: 887    
Foell J, Pfirstinger B, Rehe K, Wolff D, Holler E, Corbacioglu S Haploidentical stem cell transplantation with CD3+-/CD19+- depleted peripheral stem cells for patients with advanced stage sickle cell disease and no alternative donor: results of a pilot study. Bone marrow transplantation 2017, 52: 938    
Foulon S, Brennan B, Gaspar N, Dirksen U, Jeys L, Cassoni A, Claude L, Seddon B, Marec-Berard P, Whelan J, Paulussen M, Streitbuerger A, Oberlin O, Jürgens H, Grimer R, Le Deley MC Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E. W.I. N.G group. European journal of cancer 2016, 61: 128    
Franzius C, Bielack S, Sciuk J, Vollet B, Jürgens H, Schober O High-activity samarium-153-EDTMP therapy in unresectable osteosarcoma. Nuklearmedizin 1999, 38: 337    
Franzius C, Sciuk J, Brinkschmidt C, Jürgens H, Schober O Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis. Clinical Nuclear Medicine 2000, 25: 874    
Franzius C, Sciuk J, Daldrup-Link H, Jürgens H, Schober O FDG-PET for detection of osseous metastases from malignant primary bone tumors. Eur J Nucl Med 2000, 27: 1305    
Franzius C, Daldrup-Link H, Sciuk J, Rummeny E, Bielack S, Jürgens H, Schober O FDG-PET for detection of pulmonary metastases from malignant primary bone tumors. Ann Oncol 2001, 12: 479    
Franzius C, Schulte M, Hillmann A, Winkelmann W, Jürgens H, Bockisch A, Schober O Klinische Wertigkeit der Positronenemissionstomographie (PET) in der Diagnostik der Knochen- und Weichteiltumore. Chirurg 2001, 72: 1071    
Franzius C, Bielack S, Flege S, Sciuk J, Jürgens H, Schober O Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in primary osteosarcoma. J Nucl Med 2002, 43: 1012    
Franzius C, Daldrup-Link H, Wagner-Bohn A, Sciuk J, Heindel W, Jürgens H, Schober O FDG-PET for detection of recurrences from malignant primary bone tumors. Ann Oncol 2002, 13: 157    
Franzius C, Schuck A, Bielack S High-dose samarium-153 ethylene diamine tetramethylene phosphonate. J Clin Oncol 2002, 20: 1953    
Franzius C, Hotfilder M, Poremba C, Hermann S, Schafers K, Gabbert HE, Jürgens H, Schober O, Schafers M, Vormoor J Successful high-resolution animal positron emission tomography of human Ewing tumours and their metastases in a murine xenograft model. European journal of nuclear medicine and molecular imaging 2006, 33: 1432    
Franzius C, Juergens KU, Vormoor J PET/CT with diagnostic CT in the evaluation of childhood sarcoma. AJR. American journal of roentgenology 2006, 186: 581; author reply 581    
Franke M, Hardes J, Helmke K, Jundt G, Jürgens H, Kempf-Bielack B, Kevric M, Tunn PU, Werner M, Bielack S Solitary skeletal osteosarcoma recurrence. Findings from the Cooperative Osteosarcoma Study Group. Pediatr Blood Cancer 2011, 56: 771    
Franke M, Hardes J, Helmke K, Jundt G, Jürgens H, Kempf-Bielack B, Kevric M, Tunn PU, Werner M, Bielack S Solitary skeletal osteosarcoma recurrence. Findings from the Cooperative Osteosarcoma Study Group. Pediatric blood & cancer 2011, 56: 771    
Frank JA, Ranft A, Paulussen M, Jürgens H, Kruseova J, Bauer S, Niggli F, Reichardt P, Dirksen U Results for patients with sarcoma not otherwise specified and other diagnoses than Ewing sarcoma treated according to the Euro-EWING 99 trial. Pediatric blood & cancer 2017, 64    
Freidank C Wegweiser für zu Hause. Leitung der bundesweiten Arbeitsgruppe pädiatrisch-onkologischer Kinderkrankenschwestern und Kinderkrankenpfleger (GPONG: German Pediatric Oncology Nurses Group) 2002    
Friedman JM, Birch PH Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. Am J Med Genet 1997, 70: 138    
Friesen C, Fulda S, Debatin K Induction of CD95 ligand and apoptosis by doxorubicin is modulated by the redox state in chemosensitive- and drug-resistant tumor cells. Cell Death Differ 1999, 6: 471    
Friedrich C, von Bueren AO, von Hoff K, Gerber NU, Ottensmeier H, Deinlein F, Benesch M, Kwiecien R, Pietsch T, Warmuth-Metz M, Faldum A, Kuehl J, Kortmann RD, Rutkowski S Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy. Neuro-oncology 2013, 15: 224    
Friedrich C, Warmuth-Metz M, von Bueren AO, Nowak J, Bison B, von Hoff K, Pietsch T, Kortmann RD, Rutkowski S Primitive neuroectodermal tumors of the brainstem in children treated according to the HIT trials: clinical findings of a rare disease. Journal of neurosurgery. Pediatrics 2015, 1    
Frisch S, Christiaens M, Guntrum F, Bauer S, Blase C, Fleischhack G, Bäumer C, Geismar D, Timmermann B EP-1404: Early results of proton beam therapy in sarcomas at the West German Proton Therapy Center Essen. Radiother Oncol 2016, 119: 654    
Friedrich C, Shalaby T, Oehler C, Pruschy M, Seifert B, Picard D, Remke M, Warmuth-Metz M, Kortmann RD, Rutkowski S, Grotzer MA, von Bueren AO Tropomyosin receptor kinase C (TrkC) expression in medulloblastoma: relation to the molecular subgroups and impact on treatment response. Child's nervous system 2017, 33: 1463    
Frömmel C, Brose A, Klein J, Blankenstein O, Lobitz S Newborn screening for sickle cell disease: technical and legal aspects of a German pilot study with 38,220 participants. BioMed research international 2014, 2014, 695828    
Frühwald MC, Graf N Rhabdoide Tumoren im Kindesalter - Einheitliches Konzept für die Behandlung von Tumoren des Gehirns, der Nieren und des Weichgewebes. WIR - Informationsschrift der Aktion für krebskranke Kinder e.V. des Dachverbandes Deutsche Leukämie-Forschungshilfe 4/2006    
Frühwald MC, Krefeld B, Benesch M, Büchner J, Boos J, Ebetsberger G, Graf N, Kortmann R, Nysom K, Rutkowski S, Schneppenheim R, Siebert R, Timmermann B, Warmuth-Matz M, Hasselblatt M The European Rhabdoid Registry (EU-RHAB) – A comprehensive approach towards biology and clinical management. Neurooncology 2010, 12:ii36    
Frühwald MC, Rutkowski S ZNS-Tumoren bei Kindern und Jugendlichen. Dtsch Arztebl Int 2011; 108: 390    
Frühwald MC, Biegel JA, Bourdeaut F, Roberts CW, Chi SN Atypical teratoid/rhabdoid tumors-current concepts, advances in biology, and potential future therapies. Neuro-oncology 2016, 18: 764    
Frühwald MC, Hasselblatt M Rhabdoide Tumoren des ZNS, der Nieren und des Weichteilgewebes. in: Niemeyer C, Eggert A (Hrsg.): Pädiatrische Hämatologie und Onkologie, Springer-Verlag GmbH Deutschland 2. vollständig überarbeitete Auflage 2018, 402    
Frühwald MC, Hasselblatt M, Nemes K, Bens S, Steinbügl M, Johann PD, Kerl K, Hauser P, Quiroga E, Solano-Paez P, Biassoni V, Gil-da-Costa MJ, Perek-Polnik M, van de Wetering M, Sumerauer D, Pears J, Stabell N, Holm S, Hengartner H, Gerber NU, Grotzer M, Boos J, Ebinger M, Tippelt S, Paulus W, Furtwängler R, Hernáiz-Driever P, Reinhard H, Rutkowski S, Schlegel PG, Schmid I, Kortmann RD, Timmermann B, Warmuth-Metz M, Kordes U, Gerss J, Nysom K, Schneppenheim R, Siebert R, Kool M, Graf N Age and DNA-methylation subgroup as potential independent risk factors for treatment stratification in children with Atypical Teratoid/Rhabdoid Tumors (ATRT). Neuro-oncology 2019,    
Fröhlich B, Hotzinger H, Fritsch H Tomographical anatomy of the pelvis, pelvic floor, and related structures. Clin Anat 1997, 10: 223    
Fröhlich B, Ahrens S, Burdach S, Klingebiel T, Ladenstein R, Paulussen M, Zoubek A, Jürgens H High-dosage chemotherapy in primary metastasized and relapsed Ewing's sarcoma. (EI)CESS. Klin Pädiatr 1999, 211: 284    
Fuchs N, Winkler K Osteosarcoma. Curr Opin Oncol 1993, 5: 667    
Fuchs J, Wenderoth M, von Schweinitz D, Haindl J, Leuschner I Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma. Cancer 1998, 83: 2400    
Fuchs N, Bielack S, Epler D, Bieling P, Delling G, Körholz D, Graf N, Heise U, Jürgens H, Kotz R, Salzer-Kuntschik M, Weinel P, Werner M, Winkler K Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 1998, 9: 893    
Fuchs J, Bode U, von Schweinitz D, Weinel P, Erttmann R, Harms D, Mildenberger H Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma. Klin Pädiatr 1999, 211: 305    
Fuchs J, Rydzynski J, von Schweinitz D, Bode U, Hecker H, Weinel P, Burger D, Harms D, Erttmann R, Oldhafer K, Mildenberger H Pretreatment prognostic factors and treatment results in children with hepatoblastoma. Cancer 2002, 95: 172    
de la Fuente J, Baruchel A, Biondi A, de Bont E, Dresse MF, Suttorp M, Millot F, International BFM Group (iBFM) Study Group Chronic Myeloid Leukaemia Committee Managing children with chronic myeloid leukaemia (CML): recommendations for the management of CML in children and young people up to the age of 18 years. British journal of haematology 2014, 167: 33    
Fulda S, Honer M, Menke-Moellers I, Berthold F Antiproliferative potential of cytostatic drugs on neuroblastoma cells in vitro. Eur J Cancer 1995, 31A: 616    
Fulda S, Susin S, Kroemer G, Debatin K Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells. Cancer Res 1998, 58: 4453    
Fulda S, Jeremias I, Pietsch T, Debatin K Betulinic acid. Klin Pädiatr 1999, 211: 319    
Fulda S, Jeremias I, Steiner H, Pietsch T, Debatin K Betulinic acid. Int J Cancer 1999, 82: 435    
Fulda S, Lutz W, Schwab M, Debatin K MycN sensitizes neuroblastoma cells for drug-induced apoptosis. Oncogene 1999, 18: 1479    
Fulda S, Meyer E, Debatin K Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. Cancer Res 2000, 60: 3947    
Fulda S, Debatin KM Molekular zielgerichtete Therapien. In: Niemeyer C, Eggert A. ed. Pädiatrische Hämatologie und Onkologie Springer; 2018, 187    
Furlan I, Batz C, Flotho C, Mohr B, Lübbert M, Suttorp M, Niemeyer CM Intriguing response to azacitidine in a patient with juvenile myelomonocytic leukemia and monosomy 7. Blood 2009, 113: 2867    
Furtwängler R, Nourkami N, Alkassar M, von Schweinitz D, Schenk JP, Rübe C, Siemer S, Leuschner I, Graf N Update on relapses in unilateral nephroblastoma registered in 3 consecutive SIOP/GPOH studies - a report from the GPOH-nephroblastoma study group. Klin padiatr 2011, 223: 113    
Furtwängler R, Gooskens SL, van Tinteren H, de Kraker J, Schleiermacher G, Bergeron C, de Camargo B, Acha T, Godzinski J, Sandstedt B, Leuschner I, Vujanic GM, Pieters R, Graf N, van den Heuvel-Eibrink MM Clear Cell Sarcomas of the Kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: A report of the SIOP Renal Tumour Study Group. European journal of cancer (Oxford, England : 1990) 2013, epub ahead of print    
Furtwängler R, Schmolze M, Gräber S, Leuschner I, Amann G, Schenk JP, Niggli F, Kager L, von Schweinitz D, Graf N Pretreatment for bilateral nephroblastomatosis is an independent risk factor for progressive disease in patients with stage V nephroblastoma. Klinische Padiatrie 2014, 226: 175    
Fuhrmann S, Schabath R, Möricke A, Zimmermann M, Kunz JB, Kulozik AE, Ludwig WD, Schrappe M, Karawajew L, Ratei R Expression of CD56 defines a distinct subgroup in childhood T-ALL with inferior outcome. Results of the ALL-BFM 2000 trial. British journal of haematology 2018, 183: 96    
Furtwängler R, Graf N Nierentumoren, in: Niemeyer C, Eggert A (Hrsg.): Pädiatrische Hämatologie und Onkologie. Springer-Verlag GmbH GDeutschland 2006, 2018 2. vollständig überarbeitete Auflage 2018, 441    
Futaki M, Yamashita T, Yagasaki H, Toda T, Yabe M, Kato S, Asano S, Nakahata T The IVS4 + 4 A to T mutation of the fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients. Blood 2000, 95: 1493    
106 items found

Die Literatur-Datenbank ist alphabetisch nach dem Namen des Erstautors sortiert - bitte anklicken. Sie umfasst alle Angaben, die im Laufe der letzten Jahre von den Studienzentralen ausgewählt wurden oder die in diesem Informationsangebot referenziert werden, zum Beispiel in den Patienteninformationstexten.